Loading company…
Montara Therapeutics develops precision medicine for central nervous system disorders.
Montara Therapeutics develops medicines for central nervous system disorders using precision pharmacology, human genomics, and machine learning. Founded in 2022, the company is based in California, US. In January 2024, it raised USD 8 million in venture funding from unspecified investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in